Rockbridge Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Buy
340
+12
+4% +$12.3K 0.03% 108
2026
Q1
$302K Buy
328
+4
+1% +$4.05K 0.03% 118
2025
Q4
$348K Buy
324
+17
+6% +$16.3K 0.03% 106
2025
Q3
$234K Hold
307
– – 0.02% 125
2025
Q2
$239K Sell
307
-20
-6% -$15.5K 0.03% 127
2025
Q1
$270K Buy
327
+30
+10% +$25K 0.03% 113
2024
Q4
$229K Buy
297
+8
+3% +$6.62K 0.03% 123
2024
Q3
$256K Hold
289
– – 0.03% 109
2024
Q2
$261K Hold
289
– – 0.04% 102
2024
Q1
$225K Hold
289
– – 0.03% 111
2023
Q4
$168K Buy
+289
New +$169K 0.03% 130
2022
Q3
– Sell
-281
Closed -$91.1K – 380
2022
Q2
$91.1K Sell
281
-150
-35% -$45K 0.02% 173
2022
Q1
$126K Hold
431
– – 0.02% 198
2021
Q4
$119K Hold
431
– – 0.02% 232
2021
Q3
$99K Buy
431
+1
+0.2% +$247 0.02% 236
2021
Q2
$99K Hold
430
– – 0.02% 228
2021
Q1
$80K Sell
430
-228
-35% -$44.6K 0.02% 239
2020
Q4
$111K Buy
658
+4
+0.6% +$597 0.02% 191
2020
Q3
$97K Hold
654
– – 0.02% 193
2020
Q2
$107K Buy
+654
New +$100K 0.03% 170

Other funds holding LLY

Rockbridge Investment Management's LLY Position: Q2 2026 in Review

Rockbridge Investment Management increased its Eli Lilly (LLY) stake by 3.7% in Q2 2026, buying an estimated $12.3K and bringing the position to 340 shares worth $408K. The position accounts for 0.03% of the portfolio, ranked #108.

Rockbridge Investment Management first reported a position in LLY in Q2 2020 and has held it in 20 quarters since. 4,640 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Rockbridge Investment Management held 340 shares of Eli Lilly worth $408K as of Q2 2026.
  • Rockbridge Investment Management bought 12 Eli Lilly shares in Q2 2026, an estimated $12.3K.
  • Eli Lilly made up 0.03% of Rockbridge Investment Management's portfolio in Q2 2026, its #108 holding.
  • Rockbridge Investment Management first reported a position in Eli Lilly in Q2 2020 and has held it in 20 quarters since.
  • 4,640 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Rockbridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.